Communicable Diseases (Infectious Diseases)

Subscribe to Selected New Research on Communicable Diseases

6971 relevant articles (330 outcomes, 556 trials/studies) found for this Disease

Also Known As:

Infectious Diseases; Infectious Disease; Diseases, Infectious; Communicable Disease; Diseases, Communicable; Disease, Communicable; Disease, Infectious

Relationship Network

Disease Context: Research Results

Bacterial Infections and Mycoses

Infection: 225242

Communicable Diseases: 6971

Emerging Communicable Diseases: 46

Related Diseases

1.	Neoplasms (Cancer)
2.	Infection
3.	Acquired Immunodeficiency Syndrome (AIDS)
4.	Hypersensitivity (Allergy)
5.	Tuberculosis

Experts

1.	Rubin, R H: 7 articles (02/2008 - 01/2001)
2.	Hiramatsu, Kazufumi: 6 articles (02/2007 - 10/2002)
3.	Nasu, Masaru: 6 articles (10/2006 - 10/2002)
4.	Ljungman, P: 6 articles (04/2005 - 01/2001)
5.	Cordonnier, C: 6 articles (04/2005 - 05/2000)
6.	Nakadate, Toshihide: 5 articles (10/2006 - 10/2002)
7.	Hirakata, Yoichi: 5 articles (10/2006 - 10/2002)
8.	Shimada, Kaoru: 5 articles (10/2006 - 10/2002)
9.	Kitamura, Nobuko: 5 articles (10/2006 - 10/2002)
10.	Igari, Jun: 5 articles (10/2006 - 10/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Communicable Diseases:

1.	VaccinesIBA 11/01/2008 - "There has been a remarkable progress in the prevention,control and even eradication of infectious diseases with improved hygiene and development of antimicrobials and vaccines. " 08/01/2007 - "Breastfeeding is the best natural protection infants have against morbidity and mortality, and the development of safe and effective vaccines has made it possible to immunize children against infectious disease. " 04/01/2005 - "However, a posteriori deciphering of the biological bases for the efficacy of successful vaccines should be an essential component of research efforts directed at the development of new vaccines for the most challenging infectious diseases." 01/30/2004 - "Perhaps the most extensive experience with preventive agents is in the area of infectious diseases; vaccines have been extremely effective in preventing many such diseases. " 01/01/2003 - "New and improved diagnostic techniques for infectious diseases have been developed and new and highly effective vaccines to prevent such diseases have been introduced and more have been, or are about to be, field-tested. " Order ALL the reference details at left...
2.	Anti-Bacterial Agents (Antibiotics)IBA 02/01/2009 - "It, too, is consistent with the marked increase in the liberalization of social values in the West in the 1950s and 1960s (in part, the sexual revolution), regions that, a generation or two earlier, experienced dramatically reduced infectious diseases as a result of antibiotics, vaccinations, food- and water-safety practices, and increased sanitation. " 01/01/2007 - "Modem science through improved sanitation, vaccination and antibiotics as well as improved social and economical conditions, has eliminated the threat of death from most infectious diseases. " 01/01/2008 - "Historically, main reasons for that are four achievements of medicine: (1) improvements in common hygiene, such as waste disposal and water purification which led to the significant reduction of communicable diseases; (2) common recognition of Pasteur's Germ Theory followed by improvements in occupational and personal hygiene as well as introduction of antiseptic and aseptic measures; (3) decrease in childhood mortality due to the discovery and widespread application of vaccination; and (4) the discovery and clinical application of antibiotics. " 01/01/2007 - "Infectious disease conditions that were almost always fatal in the early 1900s are now being effectively treated with antibiotics and other modalities emanating from science and prevented through the general improvements in vaccination, nutrition, sanitation and availability of safe water to many more people. " 01/01/2009 - "Oral antibiotics are the ideal example of pharmacologic agents that are effective against inflammatory processes and have obvious roles in infectious diseases." Order ALL the reference details at left...
3.	AntigensIBA 07/01/1998 - "Although initial work focused on potential applications in infectious disease, it was soon recognized that the antigen-specific Th1 response typically generated by genetic immunization protocols could also be useful for the treatment of allergic disease. " 09/01/2007 - "In the present study, we shed more light on the humoral autoimmune response to the Rib-P antigen as it occurs in autoimmunity and infectious disease. " 01/01/2004 - "PURPOSE: The purpose of this study is to develop a simple and inexpensive method for detection of viral load or antigens present in the body fluids as for diagnosis or monitoring of infectious diseases. " 03/01/2003 - "Some well planned and designed association studies performed in Caucasians suggest that longevity is associated with positive selection of alleles (i.e. HLA-DR11) or haplotypes (i.e. HLA-B8,DR3) that confer resistance to infectious diseases, respectively, via peptide presentation or via antigen non-specific control of immune response. " 02/01/1997 - "The ineffectiveness of simple delivery of soluble antigens to mucosal membranes for immunization has stimulated extensive studies of strategies for effective delivery systems that would (a) increase the antigen absorption, (b) prevent its degradation, and (c) skew the outcome of immunization to a desired goal (protective response to infectious diseases vs. tolerance; B vs. T cell responses; mucosal vs. systemic). " Order ALL the reference details at left...
4.	DNA (Deoxyribonucleic Acid)IBA 01/01/2006 - "Due to its highly parallel approach, DNA microarray technology opens up new possibilities that may be particularly beneficial for laboratory diagnosis of infectious diseases. " 01/01/1998 - "Thus, DNA-based immunization of neonates may prove an effective and safe vaccination strategy for induction of cellular immunity against microbes that cause serious infectious diseases in the early period of life." 11/15/2005 - "Viral vectors used alone or in heterologous DNA prime/viral boost combinations have shown improved responses to certain infectious diseases. " 04/30/2001 - "DNA-vaccination holds great promise for the future of vaccine development against infectious diseases, especially in developing countries. " 06/01/2006 - "These data build on the repeated-dose toxicology studies performed (see companion article, Sheets et al., 2006) to demonstrate the safety and suitability for investigational human use of DNA plasmid vaccine candidates for a variety of infectious disease prevention indications." Order ALL the reference details at left...
5.	AntibodiesIBA 04/01/2005 - "Especially the potential of producing therapeutic antibodies in crops that are routine dietary components of farm animals, such as corn and soy beans, seems to hold promise for future application in the fight against infectious diseases." 08/01/2003 - "Murine monoclonal and sheep polyclonal antibodies (mAbs and pAbs) to feline IFN-gamma (fIFN-gamma) were generated firstly to facilitate further research into the role of cellular immune responses in the control of feline infectious disease, and secondly to enable evaluation of the efficacy of novel immunotherapeutic approaches. " 02/05/2000 - "Topical delivery systems can provide prolonged delivery of antibodies to the vaginal mucosal surface for long-term protection against infectious diseases. " 01/01/1992 - "Secretory antibodies in mucosal surfaces are known to play an essential role in protection against various infectious diseases. " 01/01/2009 - "While only one of the 21 current FDA-approved antibodies, and one of the 38 products in advanced clinical trials target infectious diseases, there is increasing academic, government and commercial interest in this area. " Order ALL the reference details at left...
6.	Proteins (Proteins, Gene)IBA 04/15/2004 - "(Col)lectin-based chimeric proteins may thus offer promise for therapy of infectious disease." 06/21/1991 - "As a research tool, recombinant vaccinia viruses are used to synthesize biologically active proteins and analyze structure-function relations, determine the targets of humoral- and cell-mediated immunity, and investigate the immune responses needed for protection against specific infectious diseases. " 04/01/2002 - "Some recent studies have shown the role of some structural components of Mycoplasmas in pathogenesis, such as cytoskeleton proteins and adhesins, and the influence of some genetic characteristics on the development of an infectious disease." 11/01/2009 - "The application of structural genomics methods and approaches to proteins from organisms causing infectious diseases is making available the three dimensional structures of many proteins that are potential drug targets and laying the groundwork for structure aided drug discovery efforts. " 07/01/2009 - "These simple and robust immunosensors may find applications in antibody detection (for example, in diagnosis of autoimmune or infectious disease), in protein detection (especially when speed of detection is essential), and in assays for detecting enzymatic activities involved in post-translational modifications of proteins." Order ALL the reference details at left...
7.	Anti-Infective Agents (Microbicides)IBA 04/01/1992 - "Use of antimicrobial agents is highly effective in reduction of morbidity and mortality due to infectious disease. " 04/01/1985 - "A number of antimicrobial agents have been used successfully to treat patients with chronic infectious diseases in the home health care environment. " 06/01/2007 - "It is my hope that all pharmacists will understand the proper use of antimicrobial agents and thus will assure the effective and safe treatment of patients with infectious diseases." 06/01/2007 - "[PK/PD analysis and proper dosage of antimicrobial agents for effective and safe treatment of infectious diseases]" 12/01/2007 - "Various analysis based on PK-PD (pharmacokinetics-pharmacodynamics) theory were performed for prediction on the efficacy of antimicrobial agents for infectious diseases. " Order ALL the reference details at left...
8.	DNA VaccinesIBA 05/01/1997 - "DNA vaccines have been demonstrated to be effective in inducing protective cell-mediated immune responses in animal models of infectious disease. " 08/20/1999 - "The immunogenicity and protective efficacy of DNA vaccines have been amply demonstrated in numerous animal models of infectious disease. " 09/01/2006 - "This review provides an overview of studies employing particle-mediated epidermal delivery (PMED) or the gene gun to administer DNA vaccines for infectious diseases in preclinical studies employing large animal models and in human clinical trials. " 04/01/2000 - "From a series of preclinical studies and animal experiments, we have been able to demonstrate that DNA vaccines are a promising tool in strategies for protecting hosts from a variety of infectious diseases. " 04/16/2008 - "However, there have been no reports to identify the similarities and differences between these two leading physical delivery methods for DNA vaccines against infectious disease targets. " Order ALL the reference details at left...
9.	PeptidesIBA 04/26/2002 - "Thus, this peptide may provide a useful template for designing novel antifungal peptides useful for the treatment of infectious diseases." 01/01/2006 - "Currently, several studies are exploring the possibility of using these antimicrobial peptides as new therapeutic agents against different infectious diseases." 01/01/2003 - "This article is aimed at providing recent studies in our laboratory for the development of antimicrobial or antiviral peptides derived from mixture-based SCLs using cell-based assays, as well as a short review of the importance of such peptides in the control of infectious diseases. " 11/01/2009 - "In the last few years, the great impact of antimicrobial peptides on infectious disease susceptibility and natural resistance has been reported. " 07/01/2009 - "These synthetic peptides may represent novel tools for the treatment of bacterial infectious diseases." Order ALL the reference details at left...
10.	Immunologic Factors (Immunomodulators)IBA 10/01/2000 - "Certain polysaccharide immunomodulators have been identified that have profound effects in the regulation of immune responses during the progression of infectious diseases, and studies have begun to define structural aspects of these molecules that govern their function and interaction with cells of the host immune system. " 02/15/2009 - "Type I IFNs (IFN-alpha/beta) have only recently gained considerable attention as immunomodulators in nonviral infectious diseases. " 01/01/2003 - "Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers." 11/01/2001 - "Although treatment and prevention of infectious diseases are the most common reasons to use immunomodulators, other conditions, such as amelioration of stress-induced immunosuppression, maturation of the neonate's developing immune response, and strategies to reduce the metabolic cost of eliciting an immune response also are well suited for immunomodulation. " 11/01/2001 - "Immunomodulators for prevention and treatment of infectious diseases in food-producing animals." Order ALL the reference details at left...

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 05/01/1993 - "The development of medicine and chemotherapy and the improvement of sanitary conditions resulted in a marked decrease in infectious diseases. " 03/01/1993 - "These results indicate that chemotherapy with IPM/CS is effective for the treatment of severe infectious diseases accompanied by hematological disorders." 10/01/1986 - "Therefore, CPFX appears to be a very useful drug when used for chemotherapy of biliary tract infectious diseases." 10/01/1985 - "Therefore, AZT appears to be very useful drug when used for chemotherapy of infectious diseases in surgery." 07/01/1983 - "CMX therefore will be a very useful drug when used for chemotherapy of the infectious diseases of the biliary tract." Order ALL the reference details at left...
2.	Immunotherapy 06/01/2008 - "Dendritic cell (DC)-based immunotherapy has been utilized for the treatment of not only a number of human malignancies but also a select group of infectious diseases. " 08/01/2005 - "To our knowledge, this is the first description of a cell line-based immunotherapy for an infectious disease. " 10/01/2004 - "A novel immune intervention strategy to control infectious diseases is based on the use of the potent immunostimulatory properties of DC for vaccination and immunotherapy. " 12/01/2003 - "These results pave the way to a more effective immunotherapy using DCs for patients with malignancy, as well as infectious diseases." 08/01/2003 - "Elucidating the interactions of dendritic cells with microbial pathogens may lead to novel strategies for combating infectious diseases by dendritic cell-based vaccination and immunotherapy. " Order ALL the reference details at left...
3.	Transplantation (Transplant Recipients) 11/01/1996 - "Hospitals hosting a BMT Unit must fulfill several requirements which are crucial to guaranteeing the best results when faced with the complexity and aggressiveness of transplantation and possible complications, such as a blood bank, an infectious diseases department, a rehabilitation unit, the availability of consultants, as well as playworkers, teachers, psychologists and social workers. " 12/27/2002 - "However, in the recent cohort of patients who underwent transplantation after September 1995, there were no fatal cases of Epstein-Barr virus or PTLD or late mortality thus far, suggesting a benefit from improved infectious disease surveillance using currently available modalities. " 02/01/1975 - "This patient's course illustrates the severity and chronicity of immunoincompetence associated with allogeneic marrow grafting, the importance of early detection and rigorous treatment of infectious disease in these patients, and the need for improved immunologic reconstitution in human marrow transplantation. " 11/01/2009 - "Major histocompatibility complex (MHC) genetics dictate adaptive cellular immune responses, making robust MHC genotyping methods essential for studies of infectious disease, vaccine development and transplantation. " 12/01/2001 - "Macaque monkeys are frequently used in models for studies of infectious diseases, immunity, transplantation and vaccine development. " Order ALL the reference details at left...
4.	Therapeutics 01/01/2006 - "Research into the modulation of peptide gene expression in animal models, as well as the optimization of peptide-based therapeutics shows promise for the treatment and prevention of airway infectious diseases." 11/01/2009 - "Several factors that are influencing and will continue to influence epidemiology and the health of the public include factors fundamental to framing the discipline of epidemiology (i.e., its means of communication, its methodologies, its access to data, its values, its population perspective), factors relating to scientific advances (e.g., genomics, comparative effectiveness in therapeutics), and factors shaping human health (e.g., increasing globalism, the environment, disease and lifestyle, demographics, infectious disease)." 11/01/2009 - "The prevalence of antibiotic resistance among microorganisms that cause infectious diseases has resulted in the need to devise new strategies for the development of novel therapeutics. " 06/25/2009 - "These results suggest that CPMV particles could be used as a vehicle to deliver therapeutics to the damaged CNS during neurodegenerative and infectious diseases of the CNS." 03/01/2009 - "Such molecules with bifunctional activity may be potential therapeutics for infectious diseases." Order ALL the reference details at left...
5.	Transplants (Transplant) 12/01/2008 - "It is emphasized that donor quality represents a continuum of risk rather than "good or bad." A distinction is made between donor factors that generate increased risk of graft failure and factors independent of graft function, such as transmissible infectious disease or donor-derived malignancy, that may preclude a good outcome. " 02/01/2002 - "To study the extent of these differences, we conducted a survey of the practices surrounding specific infectious diseases at US renal transplant centers. " 01/27/2001 - "Humoral survey results for October 1996 through July 1999 were recorded, and clinical information on major infectious disease outcomes was obtained from chart reviews, discharge summaries, the Cleveland Clinic Unified Transplant Database, and review of all microbiological studies and pathology results for each patient. " 07/01/2009 - "Donor-derived infectious diseases appear to complicate less than 1% of all transplant procedures, but, when a transmission occurs, significant morbidity and mortality can occur. " 06/15/2009 - "METHODS: A total of 4388 SOT recipients were monitored prospectively at 16 transplant centers included in the Spanish Network for Research in Infectious Diseases (REIPI). " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Communicable Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 330 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>